Abstract
A new series of indole-based pyranoquinoline derivatives P1–24 has been synthesized by a one-pot cyclocondensation reaction of 2-(4-substituted)phenyl-N-allyl-indole-3-carbaldehydes 1a–d; active methylenes 2a–c; and 4-hydroxy-1-substituted quinolin-2(1H)-one 3a–b catalysed by an organocatalyst tetra-n-butylammonium fluoride (TBAF) in aqueous ethanol. The easy experimental procedure of the reaction leads to excellent yields of pyranoquinoline derivatives. All the compounds were screened against a representative panel of bacteria and fungi. Some of the compounds are found to be equipotent or more potent than standard drugs as evident from the structural activity relationship study.
Keywords: quinoline, indole, tetra-n-butylammonium fluoride (TBAF), anti-microbial activity
1. Introduction
Quinolines and indole are privileged heterocyclic ring moieties existing in a number of pharmacologically active natural or synthetic products, and have been used as templates for the synthesis of many drugs prescribed for a lot of pathologies. Quinolines are an important group of compounds of both natural and synthetic origins; especially those with a pyranoquinoline ring system are of considerable interest as it is a core structure and constitutes the basic skeleton of a number of alkaloids [1], such as flindersine, oricine and verprisine, which are generally seen in the plant family Rutaceae [2] (figure 1). These derivatives exhibit a wide range of biological activities [3–12] such as anti-allergic, anti-bacterial, anti-microbial, anti-coagulant, anti-tumour, anti-hypertensive, anti-algal and anti-inflammatory activities. In addition to these bioactivities, some of them show cancer cell growth inhibitory activity and have been found to be potential anti-cancer agents [13]. The pyranoquinolinone moiety is also found in many alkaloids. These are also useful intermediates for the construction of azo dyestuffs [14].
Figure 1.
Some alkaloids containing pyrano quinolinone moiety and repurposed compound similarity.
Contrariwise, the indole ring system is also probably the most pervasive heterocycle in nature. Owing to the great structural diversity and great significance of biologically active indoles [15], these derivatives have been a topic of extensive research interest in existing heterocyclic and medicinal chemistry, as they are an essential part of the amino acid tryptophan and the neurotransmitter serotonin. The indole scaffold is also found in a manifold of naturally occurring plant-based alkaloids [16]. N-1 and C-3-substituted indole derivatives show various pharmacological properties and are widely recognized to have anti-inflammatory, anti-cancer, anti-nociceptive and anti-psychotic, anti-fungal, anti-migraine, anti-parasitic, anti-tuberculosis and anti-malarial drug activities [17].
The developments of multicomponent reactions (MCRs) have attracted much attention from the vantage point of combinatorial and medicinal chemistry. Among available methods, intramolecular cyclization via multicomponent reaction is an efficient protocol for the synthesis of new pharmacologically active heterocycles [18]. A literature survey manifests that using this one-pot, three-component approach, considerable efforts have been focused on the design and development of environmentally friendly and less expensive procedures for the generation of libraries of heterocyclic compounds employing various catalysts [19–26]. Therefore, the molecular manipulation of the promising lead involves an idea to merge the separate pharmacophoric groups of analogous activity into one compound, hence making structural changes in the biological activity. Thus, in continuance to the aforementioned facts, and as a prolongation of our investigation on the synthesis of biologically active heterocyclic compounds [27–30], we attempted to report an efficient synthesis of pyranoquinoline derivatives of the substituted 2-phenyl-N-allyl-indole scaffold, which are obtained through three-component reactions of substituted indole aldehydes 1, different active methylene compounds 2 and 4-hydroxy-1-alkylquinolin-2(1H)-one 3 catalysed by tetra butyl ammonium fluoride (TBAF) in EtOH/H2O (2 : 8) (scheme 1). Also, these were biologically evaluated.
Scheme 1.
Synthetic pathway for the synthesis of pyrano quinoline derivatives of compounds 1a–d.
As tetra-n-butylammonium fluoride (TBAF) is a quaternary ammonium salt, it is widely renowned as a convenient, organic soluble source of naked fluoride ions and can be used as a phase-transfer catalyst and as a mild base. The TBAF is highly soluble in organic solvents, and weakly nucleophilic. Over the past years, TBAF has been widely used for most fluoride-assisted reactions [31], desilylation [32,33], deprotection of silyl groups [34], trifluoromethylation, fluorination [35,36], and a variety of base-catalysed reactions such as elimination, alkylation, Michael addition and aldol condensation [37–39]. The constitutions of all the products were confirmed using 1H NMR, 13C NMR, FTIR and elemental analysis. All synthesized compounds were screened for in vitro anti-microbial activity against a representative panel of bacteria and fungi using the broth microdilution minimum inhibitory concentration (MIC) method.
2. Material and methods
2.1. General procedures
Required acetophenones, phenyl hydrazine, polyphosphoric acid, anthranilic acid, diethyl/dimethyl sulphate and phosphorus oxychloride were obtained commercially. Moreover, malanonitrile, ethyl cyanoacetate and methyl cyanoacetate were obtained from Sigma-Aldrich and were used without further purification. Solvents were purified and dried before being used. The required substituted 2-phenyl-N-allyl-indole-3-carbaldehyde 1a–d was prepared by the Vilsmeier–Haack reaction according to the procedure in the literature [40]. All melting points were taken in open capillaries and are uncorrected. Thin-layer chromatography (TLC, on aluminium plates precoated with silica gel, 60F254, 0.25 mm thickness) (Merck, Darmstadt, Germany) was used for monitoring the progress of all reactions, and purity and homogeneity of the synthesized compounds; eluent-hexane : ethyl acetate (5 : 5). UV radiation and/or iodine were used as the visualizing agents. Elemental analysis (% C, H, N) was carried out with the Perkin-Elmer 2400 series-II elemental analyser (PerkinElmer, USA), and all compounds are within ±0.4% of the theoretical value. The IR spectra were recorded in KBr on a PerkinElmer Spectrum GX FT-IR Spectrophotometer (PerkinElmer, USA) and only the characteristic peaks are reported in cm−1. 1H NMR and 13C NMR spectra were recorded in DMSO-d6 on a Bruker Advance 400F (MHz) spectrometer (Bruker Scientific Corporation Ltd., Switzerland) using solvent peak as the internal standard at 400 and 100 MHz, respectively. Chemical shifts are reported in parts per million (ppm). Mass spectra were scanned on a Shimadzu LCMS 2010 spectrometer (Shimadzu, Tokyo, Japan).
2.2. General procedure for synthesis of 4-hydroxy-1-substituted quinolin-2(1H)-one 3a–b [41]
Anthranilic acid (0.1 mmol) was dissolved in 15 ml of 5% NaOH. To this clear solution dimethylsulfate/diethylsulfate (0.2 mmol) was added and the mixture was stirred for 1 h. The separated solid was filtered out and washed with cold water and dried. It was recrystallized with ethanol. After that, N-methyl/ethyl anthranilic acid (0.01 mol) was dissolved in 50 ml of acetic acid, and 50 ml of acetic anhydride was added. The reaction mixture was heated at 120°C for 6.0 h and poured into ice. After basification with NaOH, the residue was filtered. The filtrate was acidified with HCl and cooled. The solid precipitate was filtered out, washed with benzene and dried, to give the desired product, which was used without further purification.
2.3. General procedure for the synthesis of compounds P1–24
Substituted 2-phenyl-N-allyl-indole-3-carbaldehyde 1a–d (1 mmol), malononitrile/methyl cyanoacetate/ethyl cyanoacetate 2a–c (1 mmol), 4-hydroxy-1-substituted quinolin-2(1H)-one 3a–b (1 mmol) and a catalytic TBAF (20 mol%) in water : ethanol (8 : 2) were taken. The reaction mixture was heated under reflux for 3–3.5 h and the progress of the reaction was monitored by TLC. After the completion of reaction (as evidenced by TLC), the reaction mixture was cooled to room temperature and stirred magnetically for a further 20 min. The solid mass that separated was collected by filtration, washed well with ethanol (10 ml) and purified by leaching in equal volume ratio of chloroform and methanol (15 ml) to obtain pure solid sample P1–24.
Initially, 2-phenyl-1-allyl-3-indole-carbaldehyde (1 mmol), malononitrile (1 mmol) and 4-hydroxy-1-methylquinolin-2(1H)-one (1 mmol) were refluxed in H2O for 10.0 h without catalyst. Only Knoevenagel intermediate was formed with malononitrile, while no reaction progress was observed in the case of water as a solvent. TLC of the above reaction mixture showed the non-consumption of 4-hydroxy-1-methylquinolin-2(1H)-one. Successively, we tried to explore an effective system for MCRs by screening other fluoride sources under the same conditions. It was found that the fluoride ion of TBAF is more reactive than other fluoride sources (entries 6–9, table 1).
Table 1.
The effects of different catalytic amounts of TBAF and other catalysts based on the % yield of P1 in EtOH + H2O (2 : 8) under reflux.
| trials no. | catalyst | mol (%) | time (h) | yield (%) |
|---|---|---|---|---|
| 1 | TBAF | 20 | 3 | 90 |
| 2 | TBAF | 10 | 3 | 85 |
| 3 | TBAF | 5 | 4.5 | 78 |
| 5 | TBAF | 0 | 8 | trace |
| 6 | KF | 20 | 3.5 | 85 |
| 7 | CsF | 20 | 3.5 | 80 |
| 8 | NH4F | 20 | 3.5 | 78 |
| 9 | H2SiF6 | 20 | 6 | 45 |
| 10 | NaOH | 20 | 4 | 70 |
| 11 | K2CO3 | 20 | 4.5 | 40 |
The corresponding product was obtained in low yield in the presence of H2SiF6 because it prefers to afford acidic HF molecular, not basic F− anion [42]. Besides the basic F− anion, the corresponding product was obtained in a 45–70% yield in the presence of NaOH and K2CO3 (entries 10–11, table 1). Encouraged by this result, to our delight, organocatalyst TBAF provided satisfactory results.
Confident that the method would endure structural diversity, focus then shifted to optimization. We examined different conditions including catalysts and solvents to optimize the reaction. To optimize the catalyst loading, a mixture of 2-phenyl-1-allyl-3-indole-carbaldehyde, malononitrile and 4-hydroxy-1-methylquinolin-2(1H)-one was taken for a model reaction carried out under different TBAF percentages (20 mol%, 10 and 5). Higher percentage loading of the catalyst neither increased the yield nor reduced the reaction time. It was observed that 20 mol% loading of the TBAF provided the best result in terms of yield of P1 and time (entries 1–4, table 1).
Finally, the model reaction was examined and optimized using various solvents to obtain the best yield of P1. To find the most appropriate solvent for TBAF, various polar-aprotic (CH3CN, THF and DMF), polar-protic (n-BuOH, i-PrOH, MeOH, EtOH, H2O) and the mixture of (EtOH + H2O) solvents were used. Among different reaction mediums, the use of polar-protic solvents in contrast to EtOH led to a significant decrease in yield. However, it was in fact pleasing to note an appreciable increase in the yield of P1 with the choice of water as the solvent, with a drawback that the desired product obtained was a sticky solid. Hence, the relevant reaction condition was confined to the selection of the optimum EtOH : H2O proportion, and during these studies we ascertained that the best results were obtained by using EtOH : H2O (2 : 8) medium. The reactions usually completed within 3–3.5 h (monitored by TLC). Thus, we preferred to carry out the reactions using EtOH : H2O (2 : 8) as an ecofriendly and safe medium. The results are summarized in table 2.
Table 2.
The effects of different solvents on the % yield of P1 using TBAF (20 mol%) under reflux condition.
| trials no. | solvents | yield (%) |
|---|---|---|
| 1 | EtOH + H2O (5 : 5) | 60 |
| 2 | EtOH + H2O (4 : 6) | 65 |
| 3 | EtOH + H2O (3 : 7) | 85 |
| 4 | EtOH + H2O (2 : 8) | 90 |
| 5 | EtOH + H2O (1 : 9) | 80 |
| 6 | H2O | 85 |
| 7 | EtOH | 75 |
| 8 | n-BuOH | 50 |
| 9 | i-PrOH | 10 |
| 10 | MeOH | 41 |
| 11 | THF | 80 |
| 12 | ACN | 50 |
| 13 | DMF | 20 |
3. Results and discussion
3.1. Chemistry
In this study, a series of 4H-pyrano derivatives P1–P24 have been synthesized by the one-pot three-component cyclocondensation reaction of substituted 2-(4-substituted) phenyl-N-allyl-indole-3-carbaldehyde 1a–d; active methylenes 2a–c; and 4hydroxy-N-alkyl-2-quinolinone 3a–b under reflux catalysed by an organocatalyst TBAF. The above mixture under refluxing in water–ethanol mixtures of different ratios gives moderate to good yield, i.e. 50–90%. Presumably, the formation of the pyrano[3,2-c]quinoline derivatives may occur via an in situ initial formation of the heterylidene nitrile in the presence of TBAF via Knoevenagel condensation between various substituted indole aldehyde 1a–d and active methylenes 2a–c. Then, the enolate, which is obtained from the reaction between quinolinone 3a–b and TBAF, performs the Michael addition to intermediate heterylidenenitrile. This subsequently undergoes enolization followed by intramolecular cyclization reaction and then 1, 3-proton shift to give the products P1–24 exclusively. The structures of all the new synthesized compounds were established by 1H NMR, 13C NMR, FTIR and elemental analysis, and molecular weights of some selected compounds were confirmed by mass spectrometry. In 1H NMR, (DMSO-d6) spectrum of compound P5 indicated the presence of one singlet peak at δ 5.18 ppm of –CH proton, and the disappearance of a singlet from δ 10.50 ppm of –CHO clearly confirms the cyclization of Knoevenagel intermediate. The NH2 protons of the pyran ring and aromatic protons of P5 resonate as multiplets at δ 6.89–8.02 ppm. Further, disappearance of the aromatic singlet at δ 11.24 ppm stands for the secondary amine of the indole ring and confirms the N-allylation of the corresponding aldehyde. The allylic germinal cis, trans and vicinal protons resonate as a multiplet at δ 4.55–4.70 and another single geminal proton also gives a multiplet at δ 5.74–5.81. A triplet peak at δ 1.14 and a multiplet δ 4.09–4.32 project the N-ethylated protons of quinolones, while carboxylate protons show a singlet peak at δ 3.15. The IR spectrum of compound P5 exhibited characteristic absorption bands around 3315–3285 cm−1and 1680–1692 cm−1 for (asym. and sym. stretching) –NH and C = O str., respectively.
3.2. Evaluation of anti-microbial activity
The in vitro anti-microbial activity was carried out against 24 h old cultures of three bacteria and two fungi by the disc diffusion method [43]. Compounds P1–24 have been tested for their anti-bacterial activity against Escherichia coli, Salmonella typhi and Vibrio cholerae as Gram-negative bacteria and Streptococcus pneumoniae, Bacillus subtilis and Clostridium tetani as Gram-positive bacteria, and anti-fungal activity against Candida albicans and Trichophyton rubrum. Nutrient agar and potato dextrose were used to culture the bacteria and fungus, respectively. The compounds were tested at 1000 ppm in DMF solution. Ampicillin, chloramphenicol and nyastatin, griseofulvin were used as standards for comparison of anti-bacterial and anti-fungal activities, respectively. Inhibition was recorded by measuring the diameter of the inhibition zone at the end of 24 h for bacteria at 35°C and 48 h for fungus at 28°C. The results are summarized in table 3
Table 3.
Per cent yield of synthesized compounds P1–24 and their in vitro anti-microbial activity (MIC, μg ml−1). Italicized values indicate the active compounds; E.C., Escherichia coli; S.T., Salmonella typhi; V.C., Vibrio cholerae; S.P., Streptococcus pneumoniae; B.S., Bacillus subtilis; C.T., Clostridium tetani; C.A., Candida albicans; T.R., Trichophyton rubrum. MTCC, microbial-type culture collection; ‘—’ indicates not tested.
| Gram-negative bacteria | Gram-positive bacteria | fungi | |||||||
|---|---|---|---|---|---|---|---|---|---|
| E.C. | S.T. | V.C. | S.P. | B.S. | C.T. | C.A. | T.R. | ||
| yield | MTCC | MTCC | MTCC | MTCC | MTCC | MTCC | MTCC | MTCC | |
| compound | (%) | 443 | 98 | 3906 | 1936 | 441 | 449 | 227 | 297 |
| P1(R = H, R1 = CN, R2 = CH3) | 90 | 250 | 100 | 125 | 200 | 200 | 200 | 500 | 1000 |
| P2 (R = H, R1 = COOMe, R2 = CH3) | 92 | 125 | 200 | 200 | 500 | 500 | 500 | 200 | 1000 |
| P3 (R = H, R1 = COOEt, R2 = CH3) | 86 | 125 | 200 | 250 | 250 | 100 | 200 | 1000 | 500 |
| P4 (R = H, R1 = CN, R2 = CH2CH3) | 91 | 62.5 | 250 | 250 | 100 | 125 | 125 | >1000 | >1000 |
| P5 (R = H, R1 = COOMe, R2 = CH2CH3) | 87 | 200 | 250 | 250 | 200 | 100 | 100 | >1000 | >1000 |
| P6(R = H, R1 = COOEt, R2 = CH2CH3) | 91 | 100 | 100 | 125 | 100 | 250 | 250 | 500 | 500 |
| P7 (R = Br, R1 = CN, R2 = CH3) | 86 | 200 | 62.5 | 100 | 200 | 100 | 100 | 1000 | >1000 |
| P8 (R = Br, R1 = COOMe, R2 = CH3) | 88 | 100 | 100 | 250 | 200 | 250 | 250 | 1000 | >1000 |
| P9 (R = Br, R1 = COOEt, R2 = CH3) | 90 | 200 | 200 | 200 | 200 | 125 | 100 | 250 | 1000 |
| P10 (R = Br, R1 = CN, R2 = CH2CH3) | 92 | 250 | 250 | 200 | 200 | 250 | 250 | 250 | 500 |
| P11 (R = Br, R1 = COOMe, R2 = CH2CH3) | 85 | 100 | 62.5 | 250 | 200 | 62.5 | 200 | >1000 | >1000 |
| P12 (R = Br, R1 = COOEt, R2 = CH2CH3) | 86 | 200 | 125 | 100 | 100 | 100 | 200 | 1000 | >1000 |
| P13 (R = F, R1 = CN, R2 = CH3) | 82 | 100 | 100 | 200 | 200 | 200 | 250 | 1000 | 1000 |
| P14 (R = F, R1 = COOMe, R2 = CH3) | 87 | 250 | 250 | 200 | 250 | 250 | 250 | 1000 | 1000 |
| P15 (R = F, R1 = COOEt, R2 = CH3) | 90 | 250 | 250 | 250 | 500 | 200 | 200 | 250 | 500 |
| P16 (R = F, R1 = CN, R2 = CH2CH3) | 78 | 250 | 250 | 125 | 200 | 500 | 500 | 100 | >1000 |
| P17 (R = F, R1 = COOMe, R2 = CH2CH3) | 80 | 125 | 200 | 100 | 200 | 200 | 200 | 500 | >1000 |
| P18 (R = F, R1 = COOEt, R2 = CH2CH3) | 91 | 200 | 12.5 | 500 | 125 | 200 | 125 | 500 | 1000 |
| P19 (R = Cl, R1 = CN, R2 = CH3) | 93 | 250 | 100 | 200 | 200 | 125 | 100 | 250 | 500 |
| P20 (R = Cl, R1 = COOMe, R2 = CH3) | 85 | 62.5 | 100 | 500 | 500 | 125 | 100 | 1000 | >1000 |
| P21 (R = Cl, R1 = COOEt, R2 = CH3) | 87 | 100 | 200 | 200 | 200 | 200 | 62.5 | >1000 | >1000 |
| P22 (R = Cl, R1 = CN, R2 = CH2CH3) | 81 | 250 | 250 | 250 | 100 | 100 | 200 | >1000 | 1000 |
| P23 (R = Cl, R1 = COOMe, R2 = CH2CH3) | 82 | 100 | 250 | 100 | 62.5 | 100 | 200 | 500 | 1000 |
| P24 (R = Cl, R1 = COOEt, R2 = CH2CH3) | 85 | 62.5 | 100 | 125 | 100 | 100 | 125 | 100 | 500 |
| ampicillin | — | 100 | 100 | 100 | 100 | 250 | 250 | — | — |
| chloramphenicol | — | 50 | 50 | 50 | 50 | 50 | 50 | — | — |
| nystatin | — | — | — | — | — | — | — | 100 | 500 |
| griseofulvin | — | — | — | — | — | — | — | 500 | 500 |
3.2.1. Gram-positive bacteria
Against Gram-positive bacteria C. tetani, P21 (MIC 62.5 µg ml−1) was found to have outstanding activity; compounds P5, P7, P9, P19, P20 (MIC 100 µg ml−1) showed significant activity; compounds P4, P24 (MIC 125 µg ml−1) exhibited moderate activity; while compounds P1, P3, P11, P12, P15, P17, P22, P23 (MIC 200 µg ml−1) showed better activity; while compounds P6, P8, P10, P14, P15 (MIC 250 µg ml−1) were found equally potent when compared with ampicillin (MIC 250 µg ml−1).
3.2.2. Gram-negative bacteria
Compounds P4, P20 and P24 (MIC 62.5 µg ml−1) against Gram-negative bacteria E. coli and P7, P11 (MIC 62.5 µg ml−1) against S. typhi, displayed excellent potency compared to ampicillin (MIC 100 µg ml−1); whereas compounds (MIC 100 µg ml−1) P6, P8, P11, P13, P21, P23 against E. coli and P1, P6, P8, P13, P19, P20, P24 against S. typhi were equipotent compared to ampicillin (MIC 100 µg ml−1). Against Gram-positive bacteria S. pneumoniae, compound P23 (MIC 62.5 µg ml−1) was found to have outstanding activity; compounds P4, P6, P12, P17, P23 (MIC 100 µg ml−1) showed equipotent activity when compared with ampicillin (MIC 100 µg ml−1), while against B. subtilis, compound P11 (MIC 62.5 µg ml−1) displayed excellent activity; compounds P3, P5, P7, P12, P22, P23, P24 (MIC 100 µg ml−1) showed significant activity; compounds P4, P9, P19, P20 (MIC 125 µg ml−1) exhibited moderate activity; while compounds P1, P13, P15, P17, P18, P21 (MIC 200 µg ml−1) showed better activity; while compounds P6, P8, P10, P14 (MIC 250 µg ml−1) were found equally potent when compared with ampicillin (MIC 250 µg ml−1).
3.2.3. Fungi
Assessment of anti-fungal screening data table 3 revealed that, against C. albicans, compounds P24, P16 (MIC 100 µg ml−1) were found to have outstanding activity; compounds P2 (MIC 200 µg ml−1) and P9, P10, P15, P19 (MIC 250 µg ml−1) displayed significant activity; while compounds P1, P6, P17, P18, P23 showed equal potency when compared with griseofulvin (MIC 500 µg ml−1). Also on comparison with nystatin (MIC 100 µg ml−1) compounds P24, P16 (MIC 100 µg ml−1) were equivalently potent. Against T. rubrum compounds P3, P6, P10, P15, P19 and P24 (MIC 500 µg ml−1) were found to be equally potent to nystatin as well as griseofulvin (MIC 500 µg ml−1).
3.3. Structural activity relationship study
The structural activity relationship (SAR) analysis demonstrated that a change in the peripheral substituent might also affect the anti-microbial activity of title compounds. The investigation revealed that the compounds with 4-chloro and bromo phenyl rings at the 2-position of the indole nucleus and also the lipophilicity of the –COO-methyl and ethyl groups at the R1 and the R2 position, respectively, play an important role to stimulate the potency of the compounds and gave excellent results towards Gram-negative bacteria E. coli, S. typhi and V. cholera and fungal pathogens as well. Whereas, towards S. pnemoniae, compounds without or with phenyl ring substitutions of the indole nucleus and also the lipophilicity of the ethyl groups at the R1 and the R2 position were found to be highly competent and showed equal activity to that of ampicillin. Against B. subtilis and C. tetani, all compounds carrying different substitutions were found to be effective. Anti-fungal evaluation showed that 4-fluoro and chloro phenyl ring-containing compounds are the most potent. Thus, examining and analysing the activity data, it is noteworthy that the anti-microbial activity of the target compounds depends not only on the bicyclic heteroaromatic pharmacophore appended through the aryl ring but also upon their positional changes, spatial relationship and also on the nature of the peripheral substituents.
4. Conclusion
In conclusion, we have demonstrated a convenient method for the synthesis of dihydropyrano [3,2-c] quinoline derivatives of indoles by applying a three-component reaction in the presence of a commercially available, non-toxic, inexpensive, biodegradable and easy-to-handle tetra-n-butylammonium fluoride (TBAF) in aqueous ethanol. The plainness of the reaction, easy isolation procedure, excellent yields of the products and short reaction time make it an efficient route for synthesizing pyranoquinoline heterocycles. So this novel organocatalyst may find application in one-pot three-component reaction for the synthesis of pyranoquinoline derivatives also at a large scale. It can be concluded from anti-microbial screening that most of the synthesized 4H-pyran derivatives were found to be highly active against a panel of human pathogens, compared to the standard drugs. It is worth affirming that minor changes in molecular configuration due to their positional changes, spatial relationship and also the nature of the peripheral substituents of these compounds profoundly influence their activity.
Supplementary Material
Acknowledgements
The authors are thankful to Head, Department of Chemistry, Sardar Patel University for providing 1H NMR and 13C NMR spectroscopy, FT-IR and research facilities. We are also thankful to CIST, Sardar Patel University for providing mass spectrometry facilities, SICART, Vallabh Vidyanagar, for elemental analysis and Microcare Laboratory, Surat, for the biological screening of the compounds reported herein. Two of the authors (P.P. and P.G.S.) are grateful to UGC, New Delhi for BSR Research Fellowship. We honestly articulate our thanks to Head, Department of Chemistry and Sardar Patel University, Vallabh Vidyanagar for providing the necessary research facilities.
Data accessibility
We have included all the experimental data including spectral characterizations in the electronic supplementary material.
Authors' contributions
All authors have jointly contributed in carrying out this research work from the groundwork of designing to drafting of the manuscript for submission. All the authors have read and approved the manuscript for submission.
Competing interests
We declare we have no competing interests.
Funding
We received no funding for this study.
References
- 1.Chen IS, Tsai IW, Teng CM, Chen JJ, Chang YL, Ko FN, Pezzuto JM. 1997. Pyranoquinoline alkaloids from Zanthoxylum simulans. Phytochemistry 46, 525–529. (doi:10.1016/S0031-9422(97)00280-X) [Google Scholar]
- 2.Bagdi AK, Hajra A. 2014. Brønsted acidic ionic liquid catalyzed tandem reaction of 4-hydroxy-1-methyl-2-quinolone with chalcone: regioselective synthesis of pyrano[3,2-c] quinolin-2-ones. RSC Adv. 4, 23 287–23 291. (doi:10.1039/C4RA03221G) [Google Scholar]
- 3.Cairns H, Cox D, Gould KJ, Ingall AH, Suschitzky JL. 1985. New antiallergic pyrano[3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma. J. Med. Chem. 28, 1832–1842. (doi:10.1021/jm00150a014) [DOI] [PubMed] [Google Scholar]
- 4.Gholizadeh S, Radmoghadam K. 2014. Ultrasound-assisted the three-component synthesis of spiro[4H-pyrano[3,2-c]quinolin-4,3′-indoline]-2′,5(6H)-diones in water. Orient. J. Chem. 29, 1637–1641. (doi:10.13005/ojc/290450) [Google Scholar]
- 5.Asghari S, Ramezani S, Mohseni M. 2014. Synthesis and antibacterial activity of ethyl 2-amino-6-ethyl-5-oxo-4-aryl-5, 6-dihydro-4H-pyrano[3,2-c] quinoline-3-carboxylate. Chin. Chem. Lett. 25, 431–434. (doi:10.1016/j.cclet.2013.12.010) [Google Scholar]
- 6.Jardosh HH, Patel MP. 2013. Microwave-assisted CAN-catalyzed solvent-free synthesis of N-allyl quinolone-based pyrano[4,3-b]chromene and benzopyrano[3,2-c]chromene derivatives and their antimicrobial activity. Med. Chem. Res. 22, 905–915. (doi:10.1007/s00044-012-0085-z) [Google Scholar]
- 7.Kuo RY, Chang FR, Chen CY, Teng CM, Yen HF, Wu YC. 2001. Antiplatelet activity of N-methoxycarbonyl aporphines from Rollinia mucosa. Phytochemistry 57, 421–425. (doi:0.1016/S0031-9422(01)00076-0) [DOI] [PubMed] [Google Scholar]
- 8.Behforouz M, Cai W, Mohammadi F, Stocksdale MG, Gu Z, Ahmadian M, Tanzer LR. 2007. Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5, 8-diones. Bioorg. Med. Chem. 15, 495–510. (doi:10.1016/j.bmc.2006.09.039) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kumar M, Sharma K, Samarth RM, Kumar A. 2010. Synthesis and antioxidant activity of quinolinobenzothiazinones. Eur. J. Med. Chem. 45, 4467–4472. (doi:10.1016/j.ejmech.2010.07.006) [DOI] [PubMed] [Google Scholar]
- 10.Magedov IV, Manpadi M, Ogasawara MA, Dhawan AS, Rogelj S, Van Slambrouck S, Knee EJ. 2008. Structural simplification of bioactive natural products with multicomponent synthesis. 2. Antiproliferative and antitubulin activities of pyrano[3, 2-c]pyridones and pyrano[3,2-c]quinolones. J. Med. Chem. 51, 2561–2570. (doi:10.1021/jm701499n) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cantrell CL, Schrader KK, Mamonov LK, Sitpaeva GT, Kustova TS, Dunbar C, Wedge DE. 2005. Isolation and identification of antifungal and antialgal alkaloids from Haplophyllum sieversii. J. Agric. Food Chem. 53, 7741–7748. (doi:10.1021/jf051478v) [DOI] [PubMed] [Google Scholar]
- 12.Ito C, Itoigawa M, Furukawa A, Hirano T, Murata T, Kaneda N, Furukawa H. 2004. Quinolone alkaloids with nitric oxide production inhibitory activity from Orixa japonica. J. Nat. Prod. 67, 1800–1803. (doi:10.1021/np0401462) [DOI] [PubMed] [Google Scholar]
- 13.Al-Said MS, Bashandy MS, Al-Qasoumi SI, Ghorab MM. 2011. Anti-breast cancer activity of some novel 1, 2-dihydropyridine, thiophene and thiazole derivatives. Eur. J. Med. Chem. 46, 137–141. (doi:10.1016/j.ejmech.2010.10.024) [DOI] [PubMed] [Google Scholar]
- 14.Joel SP, Marson CM.2012. U.S. Patent No. 8,110,577, Washington, DC: U.S. Patent and Trademark Office.
- 15.Humphrey GR, Kuethe JT. 2006. Practical methodologies for the synthesis of indoles. Chem. Rev. 106, 2875–2911. (doi:10.1021/cr0505270) [DOI] [PubMed] [Google Scholar]
- 16.Hibino S, Choshi T. 2002. Simple indole alkaloids and those with a nonrearranged monoterpenoid unit. Nat. Prod. Rep. 19, 148–180. (doi:10.1039/B004055J) [DOI] [PubMed] [Google Scholar]
- 17.Kaushik NK, Kaushik N, Attri P, Kumar N, Kim CH, Verma AK, Choi EH. 2013. Biomedical importance of indoles. Molecules 18, 6620–6662. (doi:10.3390/molecules18066620) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mungra DC, Patel MP, Rajani DP, Patel RG. 2011b. Synthesis and identification of β-aryloxyquinolines and their pyrano[3, 2-c]chromene derivatives as a new class of antimicrobial and antituberculosis agents . Eur. J. Med. Chem. 46, 4192–4200. (doi:10.1016/j.ejmech.2011.06.022) [DOI] [PubMed] [Google Scholar]
- 19.Pandit KS, Chavan PV, Desai UV, Kulkarni MA, Wadgaonkar PP. 2015. Tris-hydroxymethylaminomethane (THAM): a novel organocatalyst for a environmentally benign synthesis of medicinally important tetrahydrobenzo[b]pyrans and pyran-annulated heterocycles. New J. Chem. 39, 4452–4463. (doi:10.1039/C4NJ02346C) [Google Scholar]
- 20.Baghbanian SM, Rezaei N, Tashakkorian H. 2013. Nanozeolite clinoptilolite as a highly efficient heterogeneous catalyst for the synthesis of various 2-amino-4H-chromene derivatives in aqueous media. Green Chem. 15, 3446–3458. (doi:10.1039/C3GC41302K) [Google Scholar]
- 21.Wang DC, Xie YM, Fan C, Yao S, Song H. 2014. Efficient and mild cyclization procedures for the synthesis of novel 2-amino-4H-pyran derivatives with potential antitumor activity. Chin. Chem. Lett. 25, 1011–1013. (doi:10.1016/j.cclet.2014.04.026) [Google Scholar]
- 22.Bhupathi R, Madhu B, Devi BR, Reddy C, Ramana V, Dubey PK. 2016. DBU acetate mediated: one-pot multi component syntheses of dihydropyrano[3, 2-c]quinolones. J. Heterocycl. Chem. 53, 1911–1916. (doi:10.1002/jhet.2506) [Google Scholar]
- 23.Bhat SI, Trivedi DR. 2014. A highly efficient and green cascade synthesis of 3-methyl-substituted-4-hydroxy-1-methyl-quinolin-2(1H)-ones under solvent- and catalyst-free conditions. RSC Adv. 4, 11 300–11 304. (doi:10.1039/C3RA45208E) [Google Scholar]
- 24.Elinson MN, Ryzhkov FV, Nasybullin RF, Vereshchagin AN, Egorov MP. 2016. Fast efficient and general PASE approach to medicinally relevant 4H, 5H-pyrano[4,3-b]pyran-5-one and 4, 6-dihydro-5H-pyrano-[3, 2-c]pyridine-5-one scaffolds. Helv. Chim. Acta 99, 724–731. (doi:10.1002/hlca.201600150) [Google Scholar]
- 25.Wagh YB, Tayade YA, Padvi SA, Patil BS, Patil NB, Dalal DS. 2015. A cesium fluoride promoted efficient and rapid multicomponent synthesis of functionalized 2-amino-3-cyano-4H-pyran and spirooxindole derivatives. Chin. Chem. Lett. 26, 1273–1277. (doi:10.1016/j.cclet.2015.06.014) [Google Scholar]
- 26.Mohammadzadeh I, Sheibani H. 2012. A convenient one-pot synthesis of new chromeno [3,4-c] chromene and chromeno [3,4-c] pyridine derivatives in the presence of high surface area of magnesium oxide. Chin. Chem. Lett. 23, 1327–1330. (doi:10.1016/j.cclet.2012.10.007) [Google Scholar]
- 27.Thumar NJ, Patel MP. 2011a. Synthesis and antimicrobial activity of some new N-substituted quinoline derivatives of 1H-Pyrazole. Arch Pharm Chem. Life Sci. 344, 91–101. (doi:10.1002/ardp.201000010) [DOI] [PubMed] [Google Scholar]
- 28.Kathrotiya HG, Patel RG, Patel MP. 2012. Microwave-assisted multi-component synthesis of 3′-indolyl substituted pyrano[2,3-c]pyrazoles and their antimicrobial activity. J. Serb. Chem. Soc. 77, 983–991. (doi:10.2298/JSC110805199K) [Google Scholar]
- 29.Vala ND, Jardosh HH, Patel MP. 2016. PS-TBD triggered general protocol for the synthesis of 4H-chromene, pyrano[4,3-b]pyran and pyrano [3,2-c]chromene derivatives of 1H-pyrazole and their biological activities. Chin. Chem. Lett. 27, 168–172. (doi:10.1016/j.cclet.2015.09.020) [Google Scholar]
- 30.Barluenga J, Andina F, Fernández-Rodríguez MA, García-García P, Merino I, Aguilar E. 2004. Fluoride-promoted oxidation of Fischer alkoxy carbene complexes: stoichiometric and catalytic conditions. J. Org Chem. 69, 7352–7354. (doi:10.1021/jo048736s) [DOI] [PubMed] [Google Scholar]
- 31.Denmark SE, Sweis RF. 2001. Fluoride-free cross-coupling of organosilanols. J. Am. Chem. Soc. 123, 6439–6440. (doi:10.1021/ja016021q) [DOI] [PubMed] [Google Scholar]
- 32.Mattson AE, Zuhl AM, Reynolds TE, Scheidt KA. 2006. Direct nucleophilic acylation of nitroalkenes promoted by a fluoride anion/thiourea combination. J. Am. Chem. Soc. 128, 4932–4933. (doi:10.1021/ja056565i) [DOI] [PubMed] [Google Scholar]
- 33.Crouch RD. 2004. Selective monodeprotection of bis-silyl ethers. Tetrahedron 60, 5833–5871. (doi:10.1016/j.tet.2004.04.042) [Google Scholar]
- 34.Yin J, Zarkowsky DS, Thomas DW, Zhao MM, Huffman MA. 2004. Direct and convenient conversion of alcohols to fluorides. Org. Lett. 6, 1465–1468. (doi:10.1021/ol049672a) [DOI] [PubMed] [Google Scholar]
- 35.Sun H, DiMagno SG. 2005. Anhydrous tetrabutylammonium fluoride. J. Am. Chem. Soc. 127, 2050–2051. (doi:10.1021/ja0440497) [DOI] [PubMed] [Google Scholar]
- 36.Clark JH. 1980. Fluoride ion as a base in organic synthesis. Chem. Rev. 80, 429–452. (doi:10.1021/cr60327a004) [Google Scholar]
- 37.Gao S, Tseng C, Tsai CH, Yao CF. 2008. Fluoride ion-catalyzed conjugate addition for easy synthesis of 3-sulfanylpropionic acid from thiol and α, β-unsaturated carboxylic acid. Tetrahedron 64, 1955–1961. (doi:10.1016/j.tet.2007.11.064) [Google Scholar]
- 38.Ooi T, Maruoka K. 2004. Asymmetric organocatalysis of structurally well-defined chiral quaternary ammonium fluorides. Acc. Chem. Res. 37, 526–533. (doi:10.1021/ar030060k) [DOI] [PubMed] [Google Scholar]
- 39.Nyffeler PT, Durón SG, Burkart MD, Vincent SP, Wong CH. 2005. Selectfluor: mechanistic insight and applications. Angew. Chem. Int. Ed. 44, 192–212. (doi:10.1002/anie.200400648) [DOI] [PubMed] [Google Scholar]
- 40.Heda LC, Sharma R, Pareek C, Chaudhari PB. 2009. Synthesis and antimicrobial activity of some derivatives of 5-substituted indole dihydropyrimidines. J. Chem. 6, 770–774. (doi:10.1155/2009/893812) [Google Scholar]
- 41.Bhudevi B, Ramana PV, Mudiraj A, Reddy AR. 2009. Synthesis of 4-hydroxy-3-formylideneamino-1H/methyl/phenylquinolin-2-ones. Indian J. Chem. Sect. B 48, 255 (doi:123456789/3425) [Google Scholar]
- 42.Gao S, Tsai CH, Tseng C, Yao CF. 2008. Fluoride ion catalyzed multicomponent reactions for efficient synthesis of 4H-chromene and N-arylquinoline derivatives in aqueous media. Tetrahedron 64, 9143–9149. (doi:10.1016/j.tet.2008.06.061) [Google Scholar]
- 43.Collins CH, Lyne PM. 1970. Microbiological methods. Baltimore, MD: University Park Press.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
We have included all the experimental data including spectral characterizations in the electronic supplementary material.


